Artificial Intelligence Anxiety and Exercise Perception
NCT ID: NCT07102420
Last Updated: 2025-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
663 participants
OBSERVATIONAL
2025-08-20
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sedentary individuals
Sedentary individuals who have not engaged in regular exercise within the past six months, who have been exposed to basic concepts of artificial intelligence (through media, news, education, etc.), who possess sufficient cognitive ability to complete the questionnaires, and who do not have any chronic neurological, orthopedic, cardiovascular, or psychological conditions.
Questionnaire and Physical Exam
Artificial Intelligence Anxiety Scale, Exercise Benefits/Barriers Scale
Athletes
Licensed athletes who have engaged in regular exercise or sports at least twice a week during the past six months, who have been exposed to basic concepts of artificial intelligence (through media, news, education, etc.), who possess sufficient cognitive capacity to complete the questionnaires, and who do not have any chronic neurological, orthopedic, cardiovascular, or psychological conditions.
Questionnaire and Physical Exam
Artificial Intelligence Anxiety Scale, Exercise Benefits/Barriers Scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire and Physical Exam
Artificial Intelligence Anxiety Scale, Exercise Benefits/Barriers Scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having engaged in regular exercise or sports at least twice a week over the past six months (for athlete group)
* Not having engaged in regular exercise during the past six months (for sedentary group)
* Being exposed to basic concepts of artificial intelligence (via media, news, education, etc.)
* Having sufficient cognitive ability to complete the questionnaires
Exclusion Criteria
* Having a serious physical disability that prevents participation in exercise
* Incomplete or inconsistent responses in the questionnaires
* Having undergone a recent surgical operation
* Lack of voluntary consent to participate in the study
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KTO Karatay University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Özlem Akkoyun Sert, PhD
Role: STUDY_CHAIR
KTO Karatay University
Fatma Çiftçi, PhD
Role: STUDY_CHAIR
KTO Karatay University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kto Karatay University
Konya, Karatay, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025/053
Identifier Type: -
Identifier Source: org_study_id